CD4 and diphtheria: In comparison, the authors found combination vaccines against diphtheria, tetanus and pertussis (DTaP vaccine) to be significant sources of possible cross-reactive immunity to SARS-CoV-2 spike protein, which included numerous CD4, CD8, and B cell epitopes (15).